IDMD @idmdtdi.bsky.social · 14/02/2025HBV Prophylaxis in at risk pts----credit to AGA clinical practice guideline on the prevention and treatment of hepatitis B virus reactivation in at-risk individuals (Gastroenterology 2025;168:267-284) 010
IDMD @idmdtdi.bsky.social · 13/02/2025www.health.ny.gov/press/releas... Re: mpox in NYC: 'There are no reported links between either the Georgia or New Hampshire case with the New York case'... #idskyhealth.ny.govAt present the risk to the public is low and there are no additional known community cases of mpox clade Ib. 010
IDMD @idmdtdi.bsky.social · 08/02/2025Worrisome for research #idskynytimes.comDeep Cuts to Medical Research Funds Could Hobble University BudgetsGrants from the National Institutes of Health come with additional money for overhead. Proposed funding cuts would leave colleges with large budget gaps. 010
IDMD @idmdtdi.bsky.social · 02/02/2025What about this new proposed algorithm (4th gen HIV Ag/Ab then HIV-1,-2 qualitative NAT) ? Will still detect acute infection as current algorithm and quickly identify false positive 4th gen HIV tests....academic.oup.comEstimating the economic consequences of leveraging the novel cobas® HIV-1/HIV-2 Qualitative NAT Test in routine HIV testingThis research conveys the modeled economic consequences of using novel cobas® HIV-1/HIV-2 Qualitative NAT Test as an alternative option relative to the cur 000
IDMD @idmdtdi.bsky.social · 22/01/2025Jeez----https://apnews.com/article/trump-health-communications-cdc-hhs-fda-1eeca64c1ccc324b31b779a86d3999a4 'pause on regulations, guidance, announcements, press releases, social media posts and website posts until such communications had been approved by a political appointee' #idsky 140
IDMD @idmdtdi.bsky.social · 03/01/2025We must continue to find undiagnosed cases of HIV and get folks into care...hiv.govHRSA HIV/AIDS Bureau Update: Special BulletinCross-posted from: TargetHIV (PDF, 294KB) On December 20, 2024, the Health Resources and Services Administratio... 010
IDMD @idmdtdi.bsky.social · 28/12/2024Read NYT for H5N1 Updates? It is not clear how the patient in Louisiana is faring. A spokeswoman for the LA Department of Health declined on Fri to answer questions about the person’s condition. It is also not clear when in the course of the patient’s hospitalization the swabs were taken. #idskynytimes.comBird Flu Samples From Very Ill Patient Had ‘Concerning’ MutationsTiny genetic alterations could help the bird flu virus enter cells in the upper respiratory tract, the C.D.C. said. But there is no sign that mutations are widespread in nature. 020
IDMD @idmdtdi.bsky.social · 28/12/2024How do syphilis POC tests differ from laboratory-based serologic syphilis tests? -Uses whole blood -Results in 15 min -Used as an initial screening test or in conj w a non-treponemal laboratory test + clinical findings to aid in the dx of syphilis inf. -Have lower sensi/specif #idsky #syphilishhs.gov 020
IDMD @idmdtdi.bsky.social · 28/12/2024Tpox can be accessed thru the CDC’s EA-IND for patients who meet criteria that include those who: • Are severely immunocompromised • Have life-threatening mpox symptoms • Have specific skin conditions • Are pregnant, breastfeeding, or younger than 18 years of agenyc.gov 000
IDMD @idmdtdi.bsky.social · 10/12/2024Tpoxx safe but didn't improve mpox resolution or pain #idsky end of STOMPPniaid.nih.govNIH Study Finds Tecovirimat Was Safe but Did Not Improve Mpox Resolution or PainTecovirimat was safe but did not reduce the time to lesion resolution or reduce pain among adults with mild to moderate clade II mpox and a low risk of severe disease in an international study. 111
IDMD @idmdtdi.bsky.social · 10/12/2024The 2025 Immunization Schedules approved by ACIP and adopted by the CDC Director on October 24, 2024 #idsky www.cdc.gov/vaccines/hcp...cdc.govImmunization SchedulesMake sure your patients stay up to date on recommended vaccines using these schedules. 000
IDMD @idmdtdi.bsky.social · 10/12/2024"Currently lenacapavir costs $25 395–44 819 pppy (person per year)" #idsky Lenacapavir could be mass produced for <$100 pppy at launch.... To date, Gilead has not agreed lenacapavir voluntary licences with the Medicines Patent Pool. doi.org/10.1093/jac/...doi.orgLenacapavir to prevent HIV infection: current prices versus estimated costs of productionAbstractBackground. Despite improvements in treatment and oral pre-exposure prophylaxis (PrEP) access, 1.3 million people acquired HIV in 2022. Six-monthly 010
IDMD @idmdtdi.bsky.social · 10/12/2024Box 3 in the 2024 Recommendations of the International Antiviral Society–USA Panel (much better format than the DHHS Guidelines!) #idsky Gandhi RT, Landovitz RJ, Sax PE, et al. doi:10.1001/jama.2024.24543 #hivsky 010
IDMD @idmdtdi.bsky.social · 04/12/2024www.regulations.gov/docket/CDC-2... CDC is requesting input about HIV screening in clinical settings; I say go all out on true opt out testing!regulations.govRegulations.gov 000
